Shattuck Labs (STTK) Interest & Investment Income (2019 - 2026)
Shattuck Labs (STTK) reported Interest & Investment Income of $779000.0 for Q1 2026, up 13.06% year-over-year from $689000.0 in Q1 2025, and up 13.06% quarter-over-quarter from $689000.0 in Q1 2025.
Shattuck Labs (STTK) Interest & Investment Income (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has 5 years of Interest & Investment Income data on file, last reported at $779000.0 in Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $779000.0, up 13.06% year-over-year; the trailing twelve-month figure through Mar 2026 was $397000.0 (down 35.76% YoY), and the FY2025 annual result was $2.7 million, down 47.76% from the prior year.
- Interest & Investment Income improved to $779000.0 in Q1 2026 per STTK's latest filing, from $689000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $779000.0 in Q1 2026 and troughed at $689000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Shattuck Labs | 190.32 Mn | 190.32 Mn | - | 779,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 779,000.00 |
| Mar 31, 2025 | 689,000.00 |
| Dec 31, 2021 | -1.32 Mn |
| Sep 30, 2021 | 251,000.00 |
| Jun 30, 2021 | 1.00 Mn |
| Mar 31, 2021 | 696,000.00 |
| Dec 31, 2020 | 75,000.00 |
| Sep 30, 2020 | 86,000.00 |
| Jun 30, 2020 | 138,000.00 |
| Mar 31, 2020 | 250,000.00 |
| Dec 31, 2019 | 282,000.00 |
| Sep 30, 2019 | 279,000.00 |